About Axion Biosystems
Axion Biosystems is a company based in Atlanta (United States) founded in 2007 was acquired by Summa Equity in July 2021.. Axion Biosystems has raised $20.31 million across 14 funding rounds from investors including HHS, GRA Venture Fund and Summa Equity. Axion Biosystems has completed 1 acquisition, including msolv. Axion Biosystems offers products and services including MEA Maestro Pro, Omni Pro 12, and Corning Cell Counter. Axion Biosystems operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axion Biosystems, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.31 M (USD)
in 14 rounds
-
Latest Funding Round
$2.82 M (USD), Grant
Jan 01, 2020
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Summa Equity
(Jul 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Axion Biosystems
Axion Biosystems offers a comprehensive portfolio of products and services, including MEA Maestro Pro, Omni Pro 12, and Corning Cell Counter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors electrical activity in neurons and cardiomyocytes in real time.
Provides automated live-cell imaging for cellular biology analysis.
Automates brightfield and fluorescent counting of cells and organoids.
Unlock access to complete
Unlock access to complete
Funding Insights of Axion Biosystems
Axion Biosystems has successfully raised a total of $20.31M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $2.82 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $2.8M
-
First Round
First Round
(07 Jul 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Axion Biosystems | Valuation |
investors |
|
| Sep, 2018 | Amount | Series C - Axion Biosystems | Valuation |
investors |
|
| May, 2016 | Amount | Series C - Axion Biosystems | Valuation | GRA Venture Fund |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Axion Biosystems
Axion Biosystems has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, GRA Venture Fund and Summa Equity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed & early stage sector-agnostic venture capital firm funding companies in the US
|
Founded Year | Domain | Location | |
|
Summa Equity is focused on thematic and impact investments.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Axion Biosystems
Axion Biosystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include msolv. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Advanced laser and inkjet systems for manufacturing are developed.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Axion Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axion Biosystems Comparisons
Competitors of Axion Biosystems
Axion Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| domain | founded_year | HQ Location |
Single-cell imaging platform developed via magnetic levitation technology.
|
|
| domain | founded_year | HQ Location |
Cell-based phenotyping technologies and assays are provided for microbial analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axion Biosystems
Frequently Asked Questions about Axion Biosystems
When was Axion Biosystems founded?
Axion Biosystems was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Axion Biosystems located?
Axion Biosystems is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Is Axion Biosystems a funded company?
Axion Biosystems is a funded company, having raised a total of $20.31M across 14 funding rounds to date. The company's 1st funding round was a Series C of $6M, raised on Jul 07, 2008.
What does Axion Biosystems do?
Axion Biosystems was founded in 2007 in Atlanta, United States, within the biotechnology sector. Multi-electrode array technology is provided by the company to support cellular analysis in research, clinical, and drug discovery applications. Operations include the development of single-well systems, stimulating and recording channels, multi-well systems, and integrated circuits designed to reduce stimulation artifacts. Focus is placed on enabling precise data collection for scientific and therapeutic purposes.
Who are the top competitors of Axion Biosystems?
Axion Biosystems's top competitors include 10X Genomics, Mission Bio and Cellares.
What products or services does Axion Biosystems offer?
Axion Biosystems offers MEA Maestro Pro, Omni Pro 12, and Corning Cell Counter.
How many acquisitions has Axion Biosystems made?
Axion Biosystems has made 1 acquisition, including msolv.
Who are Axion Biosystems's investors?
Axion Biosystems has 3 investors. Key investors include HHS, GRA Venture Fund, and Summa Equity.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.